171 – 180 of 460
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Soluble urokinase plasminogen activator receptor as a prognostic marker in men participating in prostate cancer screening
(
- Contribution to journal › Article
-
Mark
Detection of prostate cancer : PSA
2011) p.283-334(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Prediction of Significant Prostate Cancer Diagnosed 20 to 30 Years Later With a Single Measure of Prostate-Specific Antigen at or Before Age 50
(
- Contribution to journal › Article
- 2010
-
Mark
A Common Prostate Cancer Risk Variant 5 ' of Microseminoprotein-beta (MSMB) Is a Strong Predictor of Circulating beta-Microseminoprotein (MSP) Levels in Multiple Populations
(
- Contribution to journal › Article
-
Mark
Polymorphisms at the Microseminoprotein-beta Locus Associated with Physiologic Variation in beta-Microseminoprotein and Prostate-Specific Antigen Levels
(
- Contribution to journal › Article
-
Mark
Blood Biomarker Levels to Aid Discovery of Cancer-Related Single-Nucleotide Polymorphisms: Kallikreins and Prostate Cancer.
(
- Contribution to journal › Article
-
Mark
Effect of androgen deprivation therapy on the expression of prostate cancer biomarkers MSMB and MSMB-binding protein CRISP3.
(
- Contribution to journal › Article
-
Mark
Reducing Unnecessary Biopsy During Prostate Cancer Screening Using a Four-Kallikrein Panel: An Independent Replication.
(
- Contribution to journal › Article
-
Mark
Empirical Estimates of the Lead Time Distribution for Prostate Cancer Based on Two Independent Representative Cohorts of Men Not Subject to Prostate-Specific Antigen Screening.
2010) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology May 4. p.1201-1207(
- Contribution to journal › Article
-
Mark
Identification of prostate specific antigen (PSA) isoforms in complex biological samples utilizing complementary platforms
(
- Contribution to journal › Article